Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Edo-s101
1. Edo-s101
2. 1236199-60-2
3. Minomustine
4. Edo-s 101
5. Edo-s-101
6. Tinostamustine [usan]
7. Tinostamustine(edo-s101)
8. 29dki2h2ny
9. 7-(5-(bis(2-chloroethyl)amino)-1-methyl-1h-benzo[d]imidazol-2-yl)-n-hydroxyheptanamide
10. 7-[5-[bis(2-chloroethyl)amino]-1-methylbenzimidazol-2-yl]-n-hydroxyheptanamide
11. 1h-benzimidazole-2-heptanamide, 5-[bis(2-chloroethyl)amino]-n-hydroxy-1-methyl-
12. 1h-benzimidazole-2-heptanamide, 5-(bis(2-chloroethyl)amino)-n-hydroxy-1-methyl-
13. Starbld0018955
14. Unii-29dki2h2ny
15. Tinostamustine (usan/inn)
16. Tinostamustine [inn]
17. Schembl7915449
18. Tinostamustine [who-dd]
19. Chembl3989941
20. Bcp20331
21. Ex-a1322
22. Bdbm50569838
23. Zinc68244536
24. Cs-6484
25. Db15147
26. Sb19172
27. Be170657
28. Hy-101780
29. S8769
30. D11182
31. E76854
32. 7-(5-(bis(2-chloroethyl)amino)-1-methyl-1h-benzimidazol-2-yl)-n-hydroxyheptanamide
Molecular Weight | 415.4 g/mol |
---|---|
Molecular Formula | C19H28Cl2N4O2 |
XLogP3 | 3.6 |
Hydrogen Bond Donor Count | 2 |
Hydrogen Bond Acceptor Count | 4 |
Rotatable Bond Count | 12 |
Exact Mass | 414.1589315 g/mol |
Monoisotopic Mass | 414.1589315 g/mol |
Topological Polar Surface Area | 70.4 Ų |
Heavy Atom Count | 27 |
Formal Charge | 0 |
Complexity | 438 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
63
PharmaCompass offers a list of Tinostamustine API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Tinostamustine manufacturer or Tinostamustine supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Tinostamustine manufacturer or Tinostamustine supplier.
PharmaCompass also assists you with knowing the Tinostamustine API Price utilized in the formulation of products. Tinostamustine API Price is not always fixed or binding as the Tinostamustine Price is obtained through a variety of data sources. The Tinostamustine Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Tinostamustine manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Tinostamustine, including repackagers and relabelers. The FDA regulates Tinostamustine manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Tinostamustine API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Tinostamustine supplier is an individual or a company that provides Tinostamustine active pharmaceutical ingredient (API) or Tinostamustine finished formulations upon request. The Tinostamustine suppliers may include Tinostamustine API manufacturers, exporters, distributors and traders.
Tinostamustine Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Tinostamustine GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Tinostamustine GMP manufacturer or Tinostamustine GMP API supplier for your needs.
A Tinostamustine CoA (Certificate of Analysis) is a formal document that attests to Tinostamustine's compliance with Tinostamustine specifications and serves as a tool for batch-level quality control.
Tinostamustine CoA mostly includes findings from lab analyses of a specific batch. For each Tinostamustine CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Tinostamustine may be tested according to a variety of international standards, such as European Pharmacopoeia (Tinostamustine EP), Tinostamustine JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Tinostamustine USP).